Next Article in Journal
The Equal Neutralizing Effectiveness of BNT162b2, ChAdOx1 nCoV-19, and Sputnik V Vaccines in the Palestinian Population
Previous Article in Journal
Induction of Superior Systemic and Mucosal Protective Immunity to SARS-CoV-2 by Nasal Administration of a VSV–ΔG–Spike Vaccine
Previous Article in Special Issue
Twenty-Month Monitoring of Humoral Immune Response to BNT162b2 Vaccine: Antibody Kinetics, Breakthrough Infections, and Adverse Effects
 
 
Article

Article Versions Notes

Vaccines 2024, 12(5), 492; https://doi.org/10.3390/vaccines12050492
Action Date Notes Link
article xml file uploaded 2 May 2024 09:52 CEST Original file -
article xml uploaded. 2 May 2024 09:52 CEST Update https://www.mdpi.com/2076-393X/12/5/492/xml
article pdf uploaded. 2 May 2024 09:52 CEST Version of Record https://www.mdpi.com/2076-393X/12/5/492/pdf
article supplementary file uploaded. 2 May 2024 09:52 CEST - https://www.mdpi.com/2076-393X/12/5/492#supplementary
article html file updated 2 May 2024 09:54 CEST Original file https://www.mdpi.com/2076-393X/12/5/492/html
Back to TopTop